Pfizer Upjohn and Mylan recently merged and kicked off a new subsidiary Viatris, but now the company is busy downsizing. While planning to globally restructure and let go of maximum 9,000 employees, the multinational company’s massive change is to also affect the South Korean branch.

A month after the official launch in last November, Viatris announced the organization restructuring plan. By 2024, the company would shut down and sell off maximum 15 plants to shave off production cost by at least USD 1 billion (approximately 1.1 trillion won). Due to the project, maximum 20 percent (about 9,000) of the total 45,000 employees would be affected.

Viatris has already let go of employees at